https://3b-pharma.com/wp/wp-content/uploads/2019/07/logo-1.png00imkenhttps://3b-pharma.com/wp/wp-content/uploads/2019/07/logo-1.pngimken2018-11-20 12:03:042019-09-27 14:21:33Ipsen and 3BP announce First Patient Dosed in Phase I/II study for first-in-class radionuclide (IPN01087)
